SGRY Stock Analysis: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$14.52
0.58 (4.16%)
▲
5d:
-3.39%
30d:
-4.6%
90d:
+9.3%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SGRY shows positive signals but monitor for confirmation. Market pricing in 3.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SGRY shows positive signals but monitor for confirmation. Market pricing in 3.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.54
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$18.96
23.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $14.52, which is considered oversold relative to its 30-day fair value range of $14.66 to $16.08. The stock's valuation (Forward PE: 22.9) is in line with its historical norms (25.1). Remarkably, the market is currently pricing in an annual earnings decline of 3.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SGRY is in a uptrend. Immediate support is located at $13.52, while resistance sits at $16.46. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: SGRY scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.73 (+30.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGRY is in a uptrend. Immediate support is located at $13.52, while resistance sits at $16.46. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: SGRY scores 67/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.73 (+30.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.66 -
$16.08
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (67/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 30.4% below Wall St target ($18.73)
- BULLISH: Bottoming setup score 67/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$14.66 -
$16.08
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.52
Resistance Level
$16.46
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.89
Wall Street Target
$18.73
(+30.4%)
Revenue Growth (YoY)
2.7%
Profit Margin
-2.6%
Valuation Discount vs History
-3.0% cheaper
PE vs Historical
22.9 vs 25.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.0%
(market-implied from PE analysis)
1-Year Target
$13.93
(-3%)
2-Year Target
$13.51
(-6%)
3-Year Target
$13.11
(-9%)
3-Yr Target (if PE normalizes)
(PE: 23→25)
$14.37
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.9, Growth: 29.2%)
$30.94
(+115%)
Base:
(SPY PE: 20.1, Growth: 29.2%)
$27.18
(+89%)
Bear:
(PE: 17.1, Growth: 29.2%)
$23.10
(+61%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.9 to 25.1
Stabilization Target:
$15.75
(+9.6%)
PE Expansion Potential:
+9.6%
Share & Embed Analysis
Last updated: August 23, 2026 1:36 AM ET
Data refreshes hourly during market hours. Next update: 2:36 AM
Data refreshes hourly during market hours. Next update: 2:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Doherty
SELL
8867 shares
2026-03-16
Jason Eric Evans
SELL
20400 shares
2026-03-16
Danielle Burkhalter
SELL
3469 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$455 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
